Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men

Urology

Volumn 68, Issue 3, 2006, Pages 570-574

  Ahn, Jae Ouk ^a   Ku, Ja Hyeon ^b  

^a Soonchunhyang University   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CANCER RISK; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CREATININE CLEARANCE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; MATHEMATICAL ANALYSIS; MEDICAL EXAMINATION; MEDICAL RESEARCH; MULTIPLE REGRESSION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEP WISE MULTIPLE REGRESSION;

ADULT; AGE FACTORS; BODY MASS INDEX; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN;

EID: 33748936864     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.021     Document Type: Article

References (22)

1. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317 (1987) 909-916
2. Masumori N., Tsukamoto T., Kumamoto Y., et al. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol 155 (1996) 1324-1327
3. Banfi G., Pontillo M., Dolci A., et al. Prostate-specific antigen is not increased in young men by ultraendurance sport performances. Clin Chem 43 (1997) 1465-1466
4. Savblom C., Malm J., Giwercman A., et al. Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age. Prostate 65 (2005) 66-72
5. Preston D.M., Levin L.I., Jacobson D.J., et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 56 (2000) 812-816
6. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
7. Kilic S., Yalcinkaya S., Guntekin E., et al. Determination of the site of metabolism of total, free, and complexed prostate-specific antigen. Urology 52 (1998) 470-473
8. Mast A.E., Enghild J.J., Pizzo S.V., et al. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30 (1991) 1723-1730
9. Kolb-Bachofen V., Schlepper-Schafer J., Vogell W., et al. Electron microscopic evidence for an asialoglycoprotein receptor on Kupffer cells: localization of lectin-mediated endocytosis. Cell 29 (1982) 859-866
10. Kabalin J.N., and Hornberger J.C. Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis. Urology 37 (1991) 308-310
11. Monath J.R., Burkart J.M., Freedman B.I., et al. Effect of hemodialysis on prostate-specific antigen. Urology 42 (1993) 398-400
12. Sasagawa I., Kubota Y., Hayami S., et al. Serum levels of total and free prostate specific antigen in men on hemodialysis. J Urol 160 (1998) 83-85
13. Tzanakis I., Kazoulis S., Girousis N., et al. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephrology 90 (2002) 230-233
14. 1-antichymotrypsin. J Urol 162 (1999) 897-901
15. Baillargeon J., Pollock B.H., Kristal A.R., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092-1095
16. Barqawi A.B., Golden B.K., O'Donnell C., et al. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Urology 65 (2005) 708-712
17. Ochiai A., Fritsche H.A., and Babaian R.J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 66 (2005) 819-823
18. Schuurman A.G., Goldbohm R.A., Dorant E., et al. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151 (2000) 541-549
19. Whittemore A.S., Cirillo P.M., Feldman D., et al. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of black and white Americans. J Urol 174 (2005) 872-876
20. Giovannucci E., Rimm E.B., Stampfer M.J., et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 557-563
21. Giovannucci E., Rimm E.B., Liu Y., et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95 (2003) 1240-1244
22. Lee S.E., Kwak C., Park M.S., et al. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population. Urology 56 (2000) 1007-1010